Evidence map›Paper›PMID 41534088›Full record

ArticleCancer research2026

Nerves Stimulate Cross-talk Between Gastric Cancer and Group 3 Innate Lymphoid Cells to Enhance Immunosuppression.

Fangli Liao, Yanran Tong, Hua Sun, Sen Chen, Siyang Wen, Yan-E Du, Linshan Jiang, Tong Huang, Manran Liu, Weixian Chen and 1 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Gastric cancer in the Era of neural regulation.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fangli LiaoDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0009-0009-8814-735X
Yanran TongKey Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing, China.ORCID 0009-0004-3187-877X
Hua SunDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0009-0004-6640-7177
Sen ChenDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0009-0002-4865-0590
Siyang WenDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0000-0002-8917-8379
Yan-E DuDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0009-0007-7399-3583
Linshan JiangDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0000-0002-4828-1441
Tong HuangDepartment of Surgery and Cancer, Imperial College London, London, United Kingdom.ORCID 0000-0001-8086-7883
Manran LiuKey Laboratory of Laboratory Medical Diagnostics, Chinese Ministry of Education, Chongqing Medical University, Chongqing, China.ORCID 0000-0002-3898-6878
Weixian ChenDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0000-0001-6973-9338
Liping YangDepartment of Laboratory Medicine, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.ORCID 0000-0002-9339-6846

Funding

China Postdoctoral Science Foundation () 2023T160774Chongqing Medical Young Talent Project YXQN202443Chongqing Postdoctoral Science Foundation (Postdoctoral Science Foundation of Chongqing) 2022CQBSHTB2032Chongqing Science and Technology Innovation Leading Talent Support Program BGZXM0070Chongqing Science and Technology Innovation Leading Talent Support Program CSTC2024 YCJH-General Program of Chongqing Natural Science Foundation CSTB2025NS CQ-General Program of Chongqing Natural Science Foundation GPX1130National Natural Science Foundation of China (NSFC) 82303321Natural Science Foundation of Chongqing Municipality () CSTB2023 NSCQ-Natural Science Foundation of Chongqing Municipality () MSX0125
6 · The paper itself

Abstract

The immunosuppressive tumor microenvironment (TME) enables cancer cells to evade clinical immunotherapies. Neural networks are vital components of the TME, and interactions among cancer cells, neuronal cells, and immune cells mediate immunosuppression. Hence, understanding the mechanisms of intercellular cross-talk could inform immunomodulatory approaches to enhance immunotherapy efficacy. In this study, we found that the vagus nerve regulated the cross-talk between gastric cancer cells and group 3 innate lymphoid cells (ILC3), boosting immune resistance in gastric cancer by enhancing programmed cell death ligand 1 (PD-L1) expression. Specifically, the infiltrated vagus nerve released acetylcholine (ACh) that elevated the expression of lipase ABHD16A in gastric cancer cells, facilitating the production and secretion of the metabolite lysophosphatidylserine (LysoPS) into the TME. LysoPS facilitated the proliferation and activation of ILC3s in the TME, resulting in the production of the cytokine IL22 via the GPR34-AKT-STAT3 axis. In turn, IL22 triggered the unfolded protein response (UPR) in gastric cancer cells, which led to an increase in PD-L1 expression that enhanced immune resistance. Importantly, targeting ACh or the cross-talk between gastric cancer cells and ILC3s significantly enhanced the efficacy of anti-PD-L1 immunotherapy. Serum levels of LysoPS and IL22 were elevated in patients with gastric cancer, particularly those with perineural invasion. Collectively, these findings provide valuable insights into the cross-talk among gastric cancer cells, nerve cells, and ILC3s that regulate immunosuppression and response to anti-PD-L1 immunotherapy, emphasizing the potential clinical significance of this axis for detecting and treating gastric cancer. SIGNIFICANCE: Vagus nerve-derived acetylcholine regulates cross-talk between gastric cancer cells and innate lymphoid cells to upregulate PD-L1 and promote immunosuppression, revealing potential therapeutic and diagnostic strategies for gastric cancer patients.

Indexed as

Immunity, InnateLymphocytesStomach NeoplasmsVagus NerveAcetylcholineAnimalsB7-H1 AntigenCell Line, TumorHumansImmune ToleranceTumor MicroenvironmentAcetylcholineB7-H1 AntigenCD274 protein, human

Identifiers

PMID41534088
PMCPMC13080324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.